Hypertension Channel
Topics
Medications
Quicklinks
Related Channels

What Risks Does Teveten HCT Present to a Fetus?

What Are the Risks With Taking Teveten HCT During Pregnancy?

When used in the second and third trimesters, angiotensin receptor blockers (ARBs) like Teveten HCT can cause potentially serious problems, including death, to the developing baby. Some of the problems reported in fetuses and newborns whose mothers took ARBs or angiotensin-converting enzyme inhibitors (ACE inhibitors, a similar class of medications) during the second and third trimesters of pregnancy included:
 
  • Low blood pressure (hypotension)
  • Skull deformities
  • Kidney problems, including kidney failure
  • Death.
 
In addition, low levels of amniotic fluid have been reported in pregnant women who took such medications. Low amniotic fluid levels can cause further problems in the unborn baby, such as incomplete lung development and deformities of the head and face.
 
Although these problems have not been reported with ACE inhibitor or ARB use in the first trimester, it is generally recommended that any such medications be stopped as soon as a woman becomes pregnant.
 
Hydrochlorothiazide, the other medication in Teveten HCT, may also cause problems in the fetus or newborn infant if taken during pregnancy. These potential problems include:
 
  • Jaundice (yellowing of the skin or whites of the eyes)
  • A decrease in the number of platelets in the blood (thrombocytopenia)
  • Low blood sugar levels (hypoglycemia)
  • Blood electrolyte problems, such as low sodium (hyponatremia) or low potassium (hypokalemia).
 
There may be rare instances when Teveten HCT is the only available option for treatment during pregnancy. In these instances, amniotic fluid levels should be closely monitored. If the levels become low, this medication should be stopped unless it is absolutely necessary for the mother's life.
 
Pregnancy and Pain

Teveten HCT Medication Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.